How to Select the Right Polymers for your Modified Release Tablet or Capsule, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss the most common polymers used in formulating modified release oral solid dosage forms. They will discuss how to determine best practices for polymer selection for matrix vs reservoir systems and achieving different types of modified release goals. Participants will gain an understanding of the characteristics of different polymer grades, as well as the use of other excipients in conjunction with controlled-release polymers to modify dissolution performance or processing.

Often, modified release (MR) formulations offer patient compliance, marketing and exclusivity/patent benefits over immediate-release versions. What isn’t as obvious is that MR dosage forms present their own unique set of complications around excipient selection.

Developing a modified release formulation is a common request. Often, modified release (MR) formulations offer patient compliance, marketing and exclusivity/patent benefits over immediate-release versions. What isn’t as obvious is that MR dosage forms present their own unique set of complications around excipient selection.

There are specific strategic decisions to be made concerning the desired in vivo behavior and final dosage form that critically impact formulation strategy and polymer selection. For example, do you want a tablet or capsule? Sustained release or pulsatile? Is an initial burst release of the drug desirable or not? Is there a specific zone in the GI tract where the drug should or should not release?

These decisions all have a significant impact on polymer (and other excipients) selection.

In this webinar, panelists will discuss the most common polymers used in modified release oral solid dosage form development. The speakers will distinguish between tablets and capsules, and matrix and reservoir control strategies. They will discuss the different grades of some common polymers and how those differences impact performance. The speakers will also touch on some other excipients that are commonly used in conjunction with controlled-release polymers to modify performance or processing.

Join experts Richard Sidwell, PhD, Vice President and Chief Scientific Officer, Recro®; and Charles Vesey, RPh, MS, Formulation Technologies Manager, Colorcon, Inc., in a live webinar on Wednesday, March 31, 2021 at 1pm EDT (10am PDT) to learn more about polymer selection for modified release medications.

For more information, or to register for this event, visit How to Select the Right Polymers for your Modified Release Tablet or Capsule.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x 272
Email >
Visit website